MenB vaccine offers men no protection from gonorrhoea, claims major study

BBC News (UK)State / PublicCenterFactual 85Objective 8018 hr. ago

A recent study published in the New England Journal of Medicine found that the MenB vaccine, originally designed to prevent meningitis B in infants, does not offer protection against gonorrhoea infections in men who have sex with men. The UK National Health Service began offering the vaccine to at-risk men in 2025 based on earlier reports suggesting a 38% reduction in gonorrhoea cases among vaccinated individuals. However, a two-year trial involving 587 participants found no significant difference in gonorrhoea infection rates between those receiving the vaccine and those receiving a placebo. The UK Health Security Agency stated it would continue monitoring the vaccine's impact and is not recommending immediate changes. Gonorrhoea cases remain at historically high levels, with men who have sex with men being the most affected demographic.

Bias read (Center): The article presents findings from a scientific study conducted in Australia and acknowledges the UK Health Security Agency's ongoing research. It provides balanced reporting by including perspectives from multiple experts and institutions without overtly favoring one side. The tone remains neutral,

Why these scores (Factual 85 · Objective 80): Factuality is high as the article accurately reports the findings of the Australian study and contextualizes the UK's vaccination program. Objectivity is slightly lower due to the emphasis on the study's conclusion without presenting alternative viewpoints or nuances.